Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Cao

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 2, 2024
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trialSamin K Sharma, Roxana Mehran, Birgit Vogel, et al.
International Journal of Cardiology|December 5, 2020
A sex paradox in clinical outcomes following complex percutaneous coronary interventionJohny Nicolas, Bimmer E Claessen, Davide Cao, et al.
Journal of Cardiology|May 15, 2023
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary interventionDavis Jones, Alessandro Spirito, Samantha Sartori, et al.
The Canadian Journal of Cardiology|February 13, 2022
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary InterventionCarlo Andrea Pivato, Davis Jones, Davide Cao, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2021
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCIDavide Cao, Matthew A Levin, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trialVictor Razuk, Anton Camaj, Davide Cao, et al.
Journal of Thrombosis and Thrombolysis|August 14, 2025
Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCIAngelo Oliva, Davide Cao, Mark Shneyderman, et al.
European Journal of Preventive Cardiology|October 1, 2025
Association of Neutrophil-to-Lymphocyte Ratio With Clinical Outcomes After Percutaneous Coronary InterventionAngelo Oliva, Birgit Vogel, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 10, 2020
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stentsRidhima Goel, Davide Cao, Rishi Chandiramani, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 7, 2019
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trialRobert Zilberszac, Rishi Chandiramani, Christian Hengstenberg, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 2, 2024
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trialSamin K Sharma, Roxana Mehran, Birgit Vogel, et al.
International Journal of Cardiology|December 5, 2020
A sex paradox in clinical outcomes following complex percutaneous coronary interventionJohny Nicolas, Bimmer E Claessen, Davide Cao, et al.
Journal of Cardiology|May 15, 2023
Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary interventionDavis Jones, Alessandro Spirito, Samantha Sartori, et al.
The Canadian Journal of Cardiology|February 13, 2022
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary InterventionCarlo Andrea Pivato, Davis Jones, Davide Cao, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2021
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCIDavide Cao, Matthew A Levin, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 28, 2021
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trialVictor Razuk, Anton Camaj, Davide Cao, et al.
Journal of Thrombosis and Thrombolysis|August 14, 2025
Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCIAngelo Oliva, Davide Cao, Mark Shneyderman, et al.
European Journal of Preventive Cardiology|October 1, 2025
Association of Neutrophil-to-Lymphocyte Ratio With Clinical Outcomes After Percutaneous Coronary InterventionAngelo Oliva, Birgit Vogel, Samantha Sartori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 10, 2020
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stentsRidhima Goel, Davide Cao, Rishi Chandiramani, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 7, 2019
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trialRobert Zilberszac, Rishi Chandiramani, Christian Hengstenberg, et al.
Pageof 15